Coincidence of antibodies against Hwp1 and ASCA, two distinct molecular targets of Candida albicans, reinforces the link between this fungal species and coeliac disease

References

• Lopes JP, Lionakis MS. Pathogenesis and virulence of Candida albicans. Virulence. 2022;13(1):89–6. doi: 10.1080/21505594.2021.2019950
   PubMed Web of Science ®Google Scholar
• Pappas PG, Lionakis MS, Arendrup MC, et al. Invasive candidiasis. Nat Rev Dis Primers. 2018;4(1):18026. doi: 10.1038/nrdp.2018.26
   PubMed Web of Science ®Google Scholar
• Poulain D. Candida albicans, plasticity and pathogenesis. Crit Rev Microbiol. 2015;41(2):208–217. doi: 10.3109/1040841X.2013.813904
   PubMed Web of Science ®Google Scholar
• Brown AJ, Brown GD, Netea MG, et al. Metabolism impacts upon Candida immunogenicity and pathogenicity at multiple levels. Trends Microbiol. 2014;22(11):614–622. doi: 10.1016/j.tim.2014.07.001
   PubMed Web of Science ®Google Scholar
• Sendid B, Colombel JF, Jacquinot PM, et al. Specific antibody response to oligomannosidic epitopes in Crohn’s disease, Clin Diagn Lab Immunol. Clin Diagn Lab Immunol. 1996;3(2):219–226. doi: 10.1128/cdli.3.2.219-226.1996
   PubMedGoogle Scholar
• Quinton JF, Sendid B, Reumaux D, et al. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut. 1998;42(6):788–791. doi: 10.1136/gut.42.6.788
   PubMed Web of Science ®Google Scholar
• Standaert-Vitse A, Jouault T, Vandewalle P, et al. Candida albicans is an Immunogen for anti–Saccharomyces cerevisiae antibody markers of Crohn’s disease. Gastroenterology. 2006;130(6):1764–1775. doi: 10.1053/j.gastro.2006.02.009
   PubMed Web of Science ®Google Scholar
• Sendid B, Dotan N, Nseir S, et al. Antibodies against Glucan, chitin, and Saccharomyces cerevisiae Mannan as new biomarkers of Candida albicans infection that complement tests based on C. albicans Mannan. Albicans Mannan, Clin Vaccine Immunol. 2008;15(12):1868–1877. doi: 10.1128/CVI.00200-08
   PubMedGoogle Scholar
• Alunno A, Bistoni O, Carubbi F, et al. Prevalence and significance of anti-Saccharomyces cerevisiae antibodies in primary Sjogren’s syndrome. Clin Exp Rheumatol. 2018;36(Suppl 112):73–79.
   PubMedGoogle Scholar
• Assan F, Gottlieb J, Tubach F, et al. Anti-Saccharomyces cerevisiae IgG and IgA antibodies are associated with systemic inflammation and advanced disease in hidradenitis suppurativa. J Allergy Clin Immunol. 2020;146(2):452–455 e5. doi: 10.1016/j.jaci.2020.01.045
   PubMed Web of Science ®Google Scholar
• Kvehaugen AS, Aasbrenn M, Farup PG. Anti-Saccharomyces cerevisiae antibodies (ASCA) are associated with body fat mass and systemic inflammation, but not with dietary yeast consumption: a cross-sectional study. BMC Obes. 2017;4(1):28. doi: 10.1186/s40608-017-0164-2
   PubMedGoogle Scholar
• Lang S, Duan Y, Liu J, et al. Intestinal fungal dysbiosis and systemic immune response to fungi in patients with alcoholic hepatitis. Hepatology. 2020;71:522–538. doi: 10.1002/hep.30832
   PubMed Web of Science ®Google Scholar
• Maillet J, Ottaviani S, Tubach F, et al. Anti-Saccharomyces cerevisiae antibodies (ASCA) in spondyloarthritis: prevalence and associated phenotype. Joint Bone Spine. 2016;83(6):665–668. doi: 10.1016/j.jbspin.2015.10.011
   PubMed Web of Science ®Google Scholar
• Mankai A, Sakly W, Thabet Y, et al. Anti-Saccharomyces cerevisiae antibodies in patients with systemic lupus erythematosus. Rheumatol Int. 2013;33(3):665–669. doi: 10.1007/s00296-012-2431-3
   PubMed Web of Science ®Google Scholar
• Kotze LM, Nisihara RM, Utiyama SR, et al. Antibodies anti-Saccharomyces cerevisiae (ASCA) do not differentiate Crohn’s disease from celiac disease. Arq Gastroenterol. 2010;47:242–245. doi: 10.1590/S0004-28032010000300006
   PubMedGoogle Scholar
• Doron I, Mesko M, Li XV, et al. Mycobiota-induced IgA antibodies regulate fungal commensalism in the gut and are dysregulated in Crohn’s disease. Nat Microbiol. 2021;6(12):1493–1504. doi: 10.1038/s41564-021-00983-z
   PubMed Web of Science ®Google Scholar
• Leonardi I, Gao IH, Lin WY, et al. Mucosal fungi promote gut barrier function and social behavior via type 17 immunity. Cell. 2022;185(5):831–846 e14. doi: 10.1016/j.cell.2022.01.017
   PubMed Web of Science ®Google Scholar
• Li XV, Leonardi I, Putzel GG, et al. Immune regulation by fungal strain diversity in inflammatory bowel disease. Nature. 2022;603(7902):672–678. doi: 10.1038/s41586-022-04502-w
   PubMed Web of Science ®Google Scholar
• Corouge M, Loridant S, Fradin C, et al. Humoral immunity links Candida albicans infection and celiac disease. PLoS One. 2015;10(3):e0121776. doi: 10.1371/journal.pone.0121776
   PubMed Web of Science ®Google Scholar
• Staab JF, Bradway SD, Fidel PL, et al. Adhesive and mammalian transglutaminase substrate properties of Candida albicans Hwp1. Science. 1999;283(5407):1535–1538. doi: 10.1126/science.283.5407.1535
   PubMed Web of Science ®Google Scholar
• Nieuwenhuizen WF, Pieters RH, Knippels LM, et al. Is Candida albicans a trigger in the onset of coeliac disease? Lancet. 2003;361(9375):2152–2154. doi: 10.1016/S0140-6736(03)13695-1
   PubMed Web of Science ®Google Scholar
• Aaron L, Torsten M. Candida albicans in celiac disease: a wolf in sheep’s clothing. Autoimmun Rev. 2020;19(9):102621. doi: 10.1016/j.autrev.2020.102621
   PubMed Web of Science ®Google Scholar
• Renga G, Bellet MM, Stincardini C, et al. To Be or not to Be a pathogen. Candida albicans And Celiac Disease, Front Immunol. 2019;10:2844. doi: 10.3389/fimmu.2019.02844
   PubMed Web of Science ®Google Scholar
• Poulain D, Sendid B, Standaert-Vitse A, et al. Yeasts: neglected pathogens. Dig Dis. 2009;27(Suppl 1):104–110. doi: 10.1159/000268129
   PubMedGoogle Scholar
• Barta Z. Seroreactivity against Saccharomyces cerevisiae in patients with Crohn’s disease and celiac disease. World J Gastroenterol. 2003;9(10):2308–2312. doi: 10.3748/wjg.v9.i10.2308
   PubMed Web of Science ®Google Scholar
• Papp M, Foldi I, Altorjay I, et al. Anti-microbial antibodies in celiac disease: trick or treat? World J Gastroenterol. 2009;15(31):3891–3900. doi: 10.3748/wjg.15.3891
   PubMed Web of Science ®Google Scholar
• Wolters VM, Alizadeh BZ, Weijerman ME, et al. Intestinal barrier gene variants may not explain the increased levels of antigliadin antibodies, suggesting other mechanisms than altered permeability. Hum Immunol. 2010;71(4):392–396. doi: 10.1016/j.humimm.2010.01.016
   PubMed Web of Science ®Google Scholar
• Ashorn S, Valineva T, Kaukinen K, et al. Serological responses to microbial antigens in celiac disease patients during a gluten-free diet. J Clin Immunol. 2009;29(2):190–195. doi: 10.1007/s10875-008-9255-7
   PubMed Web of Science ®Google Scholar
• Viitasalo L, Niemi L, Ashorn M, et al. Early microbial markers of celiac disease. J Clin Gastroenterol. 2014;48(7):620–624. doi: 10.1097/MCG.0000000000000089
   PubMed Web of Science ®Google Scholar
• Roggenbuck D, Goihl A, Sowa M, et al. Human glycoprotein-2 expressed in Brunner glands - a putative autoimmune target and link between Crohn’s and coeliac disease. Clin Immunol. 2023;247:109214. doi: 10.1016/j.clim.2022.109214
   PubMed Web of Science ®Google Scholar
• Laass MW, Rober N, Range U, et al. Loss and gain of tolerance to pancreatic glycoprotein 2 in Celiac disease. PLoS One. 2015;10(6):e0128104. doi: 10.1371/journal.pone.0128104
   PubMed Web of Science ®Google Scholar
• Bonneau J, Dumestre-Perard C, Rinaudo-Gaujous M, et al. Systematic review: new serological markers (anti-glycan, anti-GP2, anti-GM-CSF ab) in the prediction of IBD patient outcomes. Autoimmun Rev. 2015;14(3):231–245. doi: 10.1016/j.autrev.2014.11.004
   PubMed Web of Science ®Google Scholar
• Gross S, Bakker SF, van Bodegraven AA, et al. Increased IgA glycoprotein-2 specific antibody titres in refractory celiac disease. J Gastrointestin Liver Dis. 2014;23(2):127–133. doi: 10.15403/jgld.2014.1121.232.sg1
   PubMed Web of Science ®Google Scholar
• Viitasalo L, Iltanen S, Huhtala H, et al. First-degree relatives of celiac disease patients have increased seroreactivity to serum microbial markers. Nutrients. 2020;12(4):1073. doi: 10.3390/nu12041073
   PubMed Web of Science ®Google Scholar
• Ost KS, O’Meara TR, Stephens WZ, et al. Adaptive immunity induces mutualism between commensal eukaryotes. Nature. 2021;596(7870):114–118. doi: 10.1038/s41586-021-03722-w
   PubMed Web of Science ®Google Scholar